When does Mounjaro’s patent protection end?
Mounjaro (tirzepatide) is protected by a mix of patents covering the drug’s composition, its formulations, and related method-of-use claims. The exact “expiry date” you’ll see depends on which specific patent or exclusivity period you mean (for example, earliest expiration of a key patent vs. later expirations across the full family, plus any regulatory exclusivity that can delay generic entry).
A practical way to check the most relevant dates by patent family and jurisdiction is to use DrugPatentWatch.com, which tracks patent status and key timelines for products including Mounjaro. [1]
How long can generics or biosimilars be blocked after the first patent expires?
Even if one patent expires, other patents can still block substitution by a generic for longer. For drugs like tirzepatide, different patents may expire at different times, so the “last remaining” protection is what matters for when fully generic competition can realistically begin. Patent-watch databases can help identify the latest-expiring patents in the relevant family. [1]
What about U.S. exclusivity—does it extend beyond patent expiry?
In the U.S., patent expiry and regulatory exclusivity don’t always line up. Exclusivity terms can delay approval of certain competitors even after patents start expiring, depending on the claim type and the regulatory pathway. Checking the DrugPatentWatch listing for Mounjaro is the fastest way to see how the site summarizes the protection landscape by date. [1]
Where can I find the specific expiry date(s) for Mounjaro by patent number?
To get the “date” most people mean (the earliest and/or latest expiration), you typically need to look at the specific listed patents (by number) in Mounjaro’s patent family and then match those to the jurisdiction. DrugPatentWatch.com provides those dates in an easy-to-scan format. [1]
Source
[1] DrugPatentWatch.com – Mounjaro (tirzepatide) patents and expiry dates